Metabolic Reprogramming in Cancer: Implications for Immunosuppressive Microenvironment
Immunology · 2025-01 · 174 (1) · 30-72
DOI: 10.1111/imm.13871 ↗At a glance
Übersichtsarbeit in Immunology, published online on 2024-10-27. Written by Durre Aden and 4 co-authors. Institution: Department of Pathology, Hamdard Institute of Medical Science and Research, New Delhi, India. Major MEDLINE topics: Tumor Microenvironment, Neoplasms. Cited 56 times so far (Crossref); 519 references.
Abstract (original language)
Cancer is a complex and heterogeneous disease characterised by uncontrolled cell growth and proliferation. One hallmark of cancer cells is their ability to undergo metabolic reprogramming, which allows them to sustain their rapid growth and survival. This metabolic reprogramming creates an immunosuppressive microenvironment that facilitates tumour progression and evasion of the immune system. In this article, we review the mechanisms underlying metabolic reprogramming in cancer cells and discuss how these metabolic alterations contribute to the establishment of an immunosuppressive microenvironment. We also explore potential therapeutic strategies targeting metabolic vulnerabilities in cancer cells to enhance immune‐mediated anti‐tumour responses. Trial Registration ClinicalTrials.gov identifier: NCT02044861, NCT03163667, NCT04265534, NCT02071927, NCT02903914, NCT03314935, NCT03361228, NCT03048500, NCT03311308, NCT03800602, NCT04414540, NCT02771626, NCT03994744, NCT03229278, NCT04899921
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Pathology, Hamdard Institute of Medical Science and Research, New Delhi, India.
- Department of Pathology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India.
- Department of Radiotherapy, Jawaharlal Nehru Medical College, AMU, Aligarh, India.
- Department of Pathology and Laboratory Medicine, AIIMS, Bhopal, India.
ORCID profiles: Durre Aden, Sufian Zaheer
Cite
APA
Aden, D., Sureka, N., Zaheer, S., Chaurasia, J. K., & Zaheer, S. (2025). Metabolic Reprogramming in Cancer: Implications for Immunosuppressive Microenvironment. Immunology, 174(1), 30-72. https://doi.org/10.1111/imm.13871
Vancouver
Aden D, Sureka N, Zaheer S, Chaurasia JK, Zaheer S. Metabolic Reprogramming in Cancer: Implications for Immunosuppressive Microenvironment. Immunology. 2025;174(1):30-72. doi:10.1111/imm.13871
BibTeX
@article{Aden2025,
author = {Aden, Durre and Sureka, Niti and Zaheer, Samreen and Chaurasia, Jai Kumar and Zaheer, Sufian},
title = {Metabolic Reprogramming in Cancer: Implications for Immunosuppressive Microenvironment},
journal = {Immunology},
year = {2025},
volume = {174},
number = {1},
pages = {30--72},
doi = {10.1111/imm.13871}
}
EUVIMED